PSNL is expected to report earnings to fall 52.61% to -30 cents per share on February 20
Q4'24
Est.
$-0.30
Q3'24
Missed
by $0.29
Q2'24
Beat
by $0.13
Q1'24
Beat
by $0.15
Q4'23
Missed
by $0.04
The last earnings report on November 06 showed earnings per share of -63 cents, missing the estimate of -34 cents. With 1.15M shares outstanding, the current market capitalization sits at 75.25M.
a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies.